Giovanna Esposito Selected Research

Pyelocystitis

8/2022

Systematic review of the effect of D-mannose with or without other drugs in the treatment of symptoms of urinary tract infections/cystitis (Review).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanna Esposito Research Topics

Disease

7	Neoplasms (Cancer) 05/2021 - 09/2006
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 01/2017
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 07/2020
3	Lung Neoplasms (Lung Cancer) 07/2020 - 01/2017
1	Urinary Tract Infections (Urinary Tract Infection) 08/2022
1	Cystitis 08/2022
1	Pyelocystitis 08/2022
1	Pyuria 08/2022
1	Bacteriuria 08/2022
1	Myocarditis (Carditis) 01/2022
1	Pathologic Processes 12/2021
1	Autosomal Dominant Rhegmatogenous Retinal Detachment 07/2021
1	Neutropenia 05/2021
1	Premature Birth (Birth, Premature) 01/2021
1	Chronic Bronchitis 01/2021
1	Pneumonia (Pneumonitis) 11/2020
1	COVID-19 11/2020
1	Adenocarcinoma of Lung 04/2019
1	Carcinogenesis 11/2018
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018
1	Vomiting 01/2017
1	Necrosis 03/2010
1	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2010
1	Carcinoma (Carcinomatosis) 09/2006
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2006

Drug/Important Bio-Agent (IBA)

2	PlatinumIBA 09/2020 - 10/2019
2	pembrolizumabIBA 09/2020 - 10/2019
2	Pharmaceutical PreparationsIBA 04/2019 - 03/2010
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 03/2010 - 09/2006
1	Mannose (D-Mannose)IBA 08/2022
1	MannosidesIBA 08/2022
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2021
1	GasotransmittersIBA 12/2021
1	Carbon MonoxideIBA 12/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2021
1	Coffee FDA Link 07/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Angiogenesis InhibitorsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	prulifloxacinIBA 01/2021
1	NivolumabIBA 09/2020
1	atezolizumabIBA 07/2020
1	Monoclonal AntibodiesIBA 07/2020
1	B7-H1 AntigenIBA 10/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2019
1	Pioglitazone (Actos)FDA Link 04/2019
1	Glucose (Dextrose)FDA LinkGeneric 04/2019
1	LipidsIBA 04/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2018
1	BenzodiazepinesIBA 01/2018
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2018
1	Clonidine (ST 155)FDA LinkGeneric 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Gefitinib (Iressa)FDA Link 01/2017
1	MetalsIBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	Matrix Metalloproteinase InhibitorsIBA 03/2013
1	Liposomes (Liposome)IBA 03/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2010
1	ApoferritinsIBA 09/2006
1	matrigelIBA 09/2006
1	GadoliniumIBA 09/2006

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2017
2	Drug Therapy (Chemotherapy) 05/2021 - 07/2020
2	Immunotherapy 09/2020 - 11/2018
1	Cesarean Section (Caesarean Section) 01/2021
1	Induced Labor 01/2021